Table 2.
Demographic and baseline characteristics of studies included in this meta-analysis
| Research | year | Age (statin /contrast %) | Male (statin /contrast, %) | Diabetes (statin /contrast, %) | Hypertension (statin / contrast, %) | Dyslipidemia (statin / contrast, %) |
|---|---|---|---|---|---|---|
| Jia | 2009 | 65.4 ± 10.9/65.7 ± 12.1 | 69.9/58.3 | 19.5/21.7 | 65.5/61.7 | NA |
| STATIN STEMI | 2009 | 61 ± 11/59 ± 11 | 76.7/77.6 | 24.5/18.9 | 52.3/46.4 | NA |
| Hahn | 2011 | 55.5 ± 12.1/59.7 ± 12.8 | 85.4/82.1 | 28.1/21.4 | 43.8/46.4 | 50.6/51.2 |
| REPERATOR | 2012 | 57.5 ± 7.7/64.6 ± 10.3 | 65/86 | 5/23 | 55/23 | NA |
| Chen | 2013 | 60.71 ± 12.4/61.83 ± 12.21 | 72.4/67.5 | 28.9/31.3 | 60.5/68.8 | NA |
| He | 2013 | 66.8 ± 9.6/63.6 ± 10.4 | 74.4/68.3 | 25.6/34.1 | 65.1/61.1 | NA |
| Liu | 2013 | 59.3 ± 9.96/62.1 ± 11.4 | 81.25/78.57 | 12.5/10 | 68.75/48.57 | 25/31.43 |
| Takano | 2013 | 69 ± 10/68 ± 9 | 76.4/77.9 | 50/51.9 | 76.9/71.7 | NA |
| ROSEMARY | 2014 | 57.7 ± 12.0/57.21 ± 11.0 | 86/86 | 27/21 | 61/37 | NA |
| Su | 2014 | 65.54 ± 9.35/65.57 ± 11.45 | 85/82 | 27/21 | 61/58 | 27/33 |
| AT-STEMI | 2015 | 57.4 ± 10.7/59.1 ± 13.3 | 93.3/91.9 | 23.3/18.9 | 33.3/37.8 | 60/43.2 |
| SAMIT | 2015 | 61 ± 13/62 ± 12 | 82/75 | 20/23 | 50/49 | 36/26 |
| Shehata | 2015 | 57 ± 8/58 ± 9 | 67/68 | 52/47 | 55/57 | 38/40 |
| Yang | 2015 | 65.4 ± 9.7/65.8 ± 11.5 | 83/79 | 33/29 | 63/63 | 50/46 |
| Liu | 2016 | 61.8 ± 10.1/62.5 ± 11.2 | 73.3/71.4 | 31.8/32.7 | 65/64.1 | NA |
| RESIST-ACS | 2016 | 66.1 ± 9.3/67.7 ± 8.2 | 76.9/68.4 | 28.2/29 | 59/65.8 | 53.9/44.7 |
| Yan | 2016 | 57 ± 13/55 ± 11 | 81.36/80 | 35.59/43.64 | 64.41/58.18 | NA |
| Liu | 2017 | 57.8 ± 6.4/62.05 ± 4.16 | 43.48/53.26 | NA | NA | NA |
| Shehata | 2017 | 56 ± 9/55 ± 11 | 66/70 | 54/50 | 66/68 | 44/40 |
| García-Méndez | 2018 | 64 ± 11/64 ± 11 | 89/85 | 45/30 | 53/63 | 47/39 |
NA No data available